Reference: Campra, P. (2021). Graphene oxide detection in aqueous suspension: Observational study in optical and electron microscopy. Interim report (I). Universidad de Almería, Spain. Summary: This interim report details the microscopic analysis of a vial labelled “COMIRNATY™,” containing a cloudy aqueous suspension. Received on 06/10/2021, the sample underwent RNA extraction and quantification, revealing the presence […]
Reference: Public Health England. (2021). SARS-CoV-2 variants of concern and variants under investigation in England: Technical briefing 17 (25 June 2021). Retrieved from https://www.gov.uk/phe Summary: The Technical Briefing 17 from Public Health England, dated 25 June 2021, reports on the surveillance of SARS-CoV-2 variants in England. As of that date, there are four variants of
Reference: U.S. Department of Health and Human Services. (2021). Fact sheet for recipients and caregivers: Emergency use authorization (EUA) of the Pfizer-BioNTech COVID-19 vaccine to prevent coronavirus disease 2019 (COVID-19) in individuals 12 years of age and older. Retrieved from www.cvdvaccine.com Summary: The Pfizer-BioNTech COVID-19 Vaccine is offered under emergency use authorization (EUA) to prevent
Reference: Shimabukuro, T. T., Kim, S. Y., Myers, T. R., Moro, P. L., Oduyebo, T., Panagiotakopoulos, L., Marquez, P. L., Olson, C. K., Liu, R., Chang, K. T., Ellington, S. R., Burkel, V. K., Smoots, A. N., Green, C. J., Licata, C., Zhang, B. C., Alimchandani, M., Mba-Jonas, A., Martin, S. W., Gee, J. M.,
Reference: Shimabukuro, T. T., Kim, S. Y., Myers, T. R., Moro, P. L., Oduyebo, T., Panagiotakopoulos, L., … & Meaney-Delman, D. M. (2021). Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. New England Journal of Medicine, 384(24), 2273-2282. https://doi.org/10.1056/NEJMoa2104983 Summary: The article evaluates the safety of mRNA Covid-19 vaccines in pregnant individuals, utilising
Reference: Sadoff, J., Gray, G., Vandebosch, A., Cárdenas, V., Shukarev, G., Grinsztejn, B., Goepfert, P. A., Truyers, C., Fennema, H., Spiessens, B., Offergeld, K., Scheper, G., Taylor, K. L., Robb, M. L., Treanor, J., Barouch, D. H., Stoddard, J., Ryser, M. F., Marovich, M. A., Neuzil, K. M., Corey, L., Cauwenberghs, N., Tanner, T., Hardt,
Reference: Shinde, V., Bhikha, S., Hoosain, Z., Archary, M., Bhorat, Q., Fairlie, L., … & Madhi, S. A. (2021). Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant. The New England Journal of Medicine, 384(20), 1899-1909. https://doi.org/10.1056/NEJMoa2103055 Summary: The NVX-CoV2373 nanoparticle vaccine was evaluated in a phase 2 trial in South Africa during the B.1.351
Reference: Mair, V. (2021, April 30). Merriam-Webster gives “vaccine” a new definition. Language Log. Retrieved from https://languagelog.ldc.upenn.edu/nll/?p=50886 Summary: In a recent post, Victor Mair discusses an update to the definition of “vaccine” by Merriam-Webster. While traditional definitions describe vaccines as preparations of weakened or killed pathogens, the new entry expands this definition significantly. It now
Reference: South African Medical Research Council. (2021). Sisonke Protocol Version 4.4 dated 29 Apr 2021. Summary: The Sisonke Protocol is an open-label, single-arm phase 3B study aimed at evaluating the effectiveness of the Ad26.COV2.S COVID-19 vaccine among healthcare workers in South Africa. This study involves approximately 500,000 healthcare workers aged 18 and older, who will
Reference: Livingston, E. H., Malani, P. N., & Creech, C. B. (2021). The Johnson & Johnson vaccine for COVID-19. JAMA Patient Page. https://doi.org/10.1001/jama.2021.2927 Summary: The Johnson & Johnson COVID-19 vaccine employs a unique approach using a modified adenovirus to induce an immune response without causing infection. Unlike mRNA vaccines from Pfizer and Moderna, which require